Metabolomics paves the way for improved drug target identification

Abstract Correctly identifying candidate drugs for protein targets is crucial for drug discovery. Despite the importance of this problem for the pharmaceutical industry, chemical screening remains a challenging task, and drug–target misidentification may contribute to failures in drug development. I...

Full description

Saved in:
Bibliographic Details
Main Authors: Belinda B Garana, Nicholas A Graham
Format: Article
Language:English
Published: Springer Nature 2022-02-01
Series:Molecular Systems Biology
Online Access:https://doi.org/10.15252/msb.202210914
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849331466869145600
author Belinda B Garana
Nicholas A Graham
author_facet Belinda B Garana
Nicholas A Graham
author_sort Belinda B Garana
collection DOAJ
description Abstract Correctly identifying candidate drugs for protein targets is crucial for drug discovery. Despite the importance of this problem for the pharmaceutical industry, chemical screening remains a challenging task, and drug–target misidentification may contribute to failures in drug development. In their recent study, Sauer and colleagues (Holbrook‐Smith et al, 2022) demonstrate proof‐of‐concept for a new way to identify drug–target interactions using high‐throughput metabolomics, potentially paving the way towards a universal method for predicting drug–target relationships.
format Article
id doaj-art-69897cf6f75a4e2cad3a755e0a0a48a2
institution Kabale University
issn 1744-4292
language English
publishDate 2022-02-01
publisher Springer Nature
record_format Article
series Molecular Systems Biology
spelling doaj-art-69897cf6f75a4e2cad3a755e0a0a48a22025-08-20T03:46:34ZengSpringer NatureMolecular Systems Biology1744-42922022-02-011821210.15252/msb.202210914Metabolomics paves the way for improved drug target identificationBelinda B Garana0Nicholas A Graham1Mork Family Department of Chemical Engineering and Materials Science, University of Southern CaliforniaMork Family Department of Chemical Engineering and Materials Science, University of Southern CaliforniaAbstract Correctly identifying candidate drugs for protein targets is crucial for drug discovery. Despite the importance of this problem for the pharmaceutical industry, chemical screening remains a challenging task, and drug–target misidentification may contribute to failures in drug development. In their recent study, Sauer and colleagues (Holbrook‐Smith et al, 2022) demonstrate proof‐of‐concept for a new way to identify drug–target interactions using high‐throughput metabolomics, potentially paving the way towards a universal method for predicting drug–target relationships.https://doi.org/10.15252/msb.202210914
spellingShingle Belinda B Garana
Nicholas A Graham
Metabolomics paves the way for improved drug target identification
Molecular Systems Biology
title Metabolomics paves the way for improved drug target identification
title_full Metabolomics paves the way for improved drug target identification
title_fullStr Metabolomics paves the way for improved drug target identification
title_full_unstemmed Metabolomics paves the way for improved drug target identification
title_short Metabolomics paves the way for improved drug target identification
title_sort metabolomics paves the way for improved drug target identification
url https://doi.org/10.15252/msb.202210914
work_keys_str_mv AT belindabgarana metabolomicspavesthewayforimproveddrugtargetidentification
AT nicholasagraham metabolomicspavesthewayforimproveddrugtargetidentification